Zacks Investment Research on MSN
ANIP vs. TEVA: Which drug stock is the better buy right now?
Both ANI Pharmaceuticals ANIP and Teva Pharmaceuticals TEVA operate in the pharmaceutical sector, focusing on generic and ...
Biogen Inc.’s new at-home Alzheimer’s drug will give the company an edge over rival Eli Lilly Co.’s competing therapy, its ...
Monoclonal antibodies (mAbs) aid the body against autoimmune diseases and cancer, among other things. Patients have to pick ...
ARCALYST® (rilonacept) 2025 net product revenue of $677.5 million (unaudited), representing ~62% year-over-year growth –– ...
The Chef's Station is located inside the Imagination Cafe in City Town. It is used to make a variety of dishes that you can ...
Self-administered injectable contraceptives, which are progestin-only shots taken at home every three months, have been ...
Timing of consolidation durvalumab significantly impacts survival for patients with locally advanced non-small cell lung ...
Adolescents with Human Immunodeficiency Virus (HIV) in Botswana, South Africa, Thailand, Uganda and the United States who ...
ARCALYST- (rilonacept) 2025 net product revenue of $677.5 million (unaudited), representing ~62% year-over-year growth -- ARCALYST 2026 net product revenue expected to be $900 - $920 million -- KPL-38 ...
As prescription drug prices in the US continue to rise, political leaders across administrations, including recently US ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback